BROWSE BY TOPIC
- Bad Brokers
- Compliance Concepts
- Investor Protection
- Investments - Unsuitable
- Investments - Strategies
- Investments - Private
- Features/Scandals
- Companies
- Technology/Internet
- Rules & Regulations
- Crimes
- Investments
- Bad Advisors
- Boiler Rooms
- Hirings/Transitions
- Terminations/Cost Cutting
- Regulators
- Wall Street News
- General News
- Donald Trump & Co.
- Lawsuits/Arbitrations
- Regulatory Sanctions
- Big Banks
- People
TRENDING TAGS
Stories of Interest
- Sarah ten Siethoff is New Associate Director of SEC Investment Management Rulemaking Office
- Catherine Keating Appointed CEO of BNY Mellon Wealth Management
- Credit Suisse to Pay $47Mn to Resolve DOJ Asia Probe
- SEC Chair Clayton Goes 'Hat in Hand' Before Congress on 2019 Budget Request
- SEC's Opening Remarks to the Elder Justice Coordinating Council
- Massachusetts Jury Convicts CA Attorney of Securities Fraud
- Deutsche Bank Says 3 Senior Investment Bankers to Leave Firm
- World’s Biggest Hedge Fund Reportedly ‘Bearish On Financial Assets’
- SEC Fines Constant Contact, Popular Email Marketer, for Overstating Subscriber Numbers
- SocGen Agrees to Pay $1.3 Billion to End Libya, Libor Probes
- Cryptocurrency Exchange Bitfinex Briefly Halts Trading After Cyber Attack
- SEC Names Valerie Szczepanik Senior Advisor for Digital Assets and Innovation
- SEC Modernizes Delivery of Fund Reports, Seeks Public Feedback on Improving Fund Disclosure
- NYSE Says SEC Plan to Limit Exchange Rebates Would Hurt Investors
- Deutsche Bank faces another challenge with Fed stress test
- Former JPMorgan Broker Files racial discrimination suit against company
- $3.3Mn Winning Bid for Lunch with Warren Buffett
- Julie Erhardt is SEC's New Acting Chief Risk Officer
- Chyhe Becker is SEC's New Acting Chief Economist, Acting Director of Economic and Risk Analysis Division
- Getting a Handle on Virtual Currencies - FINRA
ABOUT FINANCIALISH
We seek to provide information, insights and direction that may enable the Financial Community to effectively and efficiently operate in a regulatory risk-free environment by curating content from all over the web.
Stay Informed with the latest fanancialish news.
SUBSCRIBE FOR
NEWSLETTERS & ALERTS
Ex-SAC Trader Granted More Time for Defense
[ by Melanie Gretchen ]
Former SAC Capital Advisors portfolio manager Mathew Martoma, who pled "not guilty" to insider trading charges, was given the benefit of the doubt by Judge Paul Gardephe, who permitted the defendant and his legal counsel more time to prepare their defense. Charles Stillman, Martoma's defense lawyer, said he has has received at least 17,000 pages of evidence from the government in recent days - which in addition to the 4 million pages of documents the government had already turned over. This includes hundreds of thousands of emails that need to be reviewed.
Meanwhile, last Friday the SEC and Stephen A. Cohen's SAC Capital agreed to settle SEC charges of insider trading against two affiliates of that firm: CR Intrinsic and Sigma Capital Management allegedly traded shares of drug and technology companies based on insider information. For Mr. Martoma, who is employed by CR Intrinsic, and is charged with illicit trading in the same drug companies, the settlement will help his defense - though it does not signify the death knell for Mr. Martoma, either.
90 Day Postponement. In the Federal District Court for the Southern District of New York, Martoma's lawyer, Charles Stillman, successfully appealed for 90 days to review the government’s evidence related to the so-called most lucrative insider trading scheme ever charged. The judge issued the delay order nearly 2 weeks before SAC Capital agreed to settle the SEC's insider trading charges. Given these new developments, the extra 90 days will be especially helpful.
Mr. Martoma was arrested in November on charges he: (i) corrupted a doctor who had access to secret drug data, and (ii) used that information to help SAC gain profits and avert losses totaling $276 million. What sets his case apart from other current and former employees indicted in prosecutors' case is that Mr. Martoma collaborated with hedge fund founder Steven Cohen who, at Mr. Martoma's recommendation, sold off almost all of his fund's holding in drug companies Elan and Wyeth, then sold the stock short. Nevertheless, Mr. Cohen, 56, has not been charged to date.
At least 8 current or former SAC employees have been connected to insider trading while employed at the firm, 4 of whom have pled guilty. The trial of Martoma will resume on 6/5.
For further details, go to [Dealbook, 3/5/13].

